China Biomarker Testing Services Market Size & Outlook
China biomarker testing services market, 2018-2030 (US$M)
Related Markets
China biomarker testing services market highlights
- The China biomarker testing services market generated a revenue of USD 13.8 million in 2021 and is expected to reach USD 27.3 million by 2030.
- The China market is expected to grow at a CAGR of 7.9% from 2022 to 2030.
- In terms of segment, biomarker assay development & validation was the largest revenue generating services in 2021.
- Flow cytometry is the most lucrative services segment registering the fastest growth during the forecast period.
Biomarker testing services market data book summary
| Market revenue in 2021 | USD 13.8 million |
| Market revenue in 2030 | USD 27.3 million |
| Growth rate | 7.9% (CAGR from 2021 to 2030) |
| Largest segment | Biomarker assay development & validation |
| Fastest growing segment | Flow cytometry |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biomarker Assay Development & Validation, Flow cytometry, Others( Biomarker immunoassays, Biomarker Assessment) |
| Key market players worldwide | Eurofins Scientific SE, SGS AG, Charles River Laboratories International Inc, Labcorp Drug Development, Thermo Fisher Scientific Inc, Icon PLC, IQVIA Holdings Inc, Syneos Health, Intertek Group PLC, BioAgilytix Labs |
Other key industry trends
- In terms of revenue, China accounted for 4.2% of the global biomarker testing services market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China biomarker testing services market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 10.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biomarker Testing Services Market Scope
Biomarker Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China biomarker testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomarker testing services market will help companies and investors design strategic landscapes.
Biomarker assay development & validation was the largest segment with a revenue share of 59.42% in 2024. Horizon Databook has segmented the China biomarker testing services market based on biomarker assay development & validation, flow cytometry, others( biomarker immunoassays, biomarker assessment) covering the revenue growth of each sub-segment from 2018 to 2030.
China is one of the most lucrative biomarker testing services markets. Growth can be attributed to the country’s increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and growing aging populations.
Besides, increased focus on drug development quality assurance, the growing establishment of specialized biomarker testing services, stringent standards around patient safety, low operating costs, growing investments, and rising R&D spending to meet consumer requirements are expected to drive the demand for outsourcing services in China.
Reasons to subscribe to China biomarker testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China biomarker testing services market databook
-
Our clientele includes a mix of biomarker testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China biomarker testing services market , including forecasts for subscribers. This country databook contains high-level insights into China biomarker testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China biomarker testing services market size, by services, 2018-2030 (US$M)
China Biomarker Testing Services Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
